• Citer

Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy.

par Casneuf, Veerle F;Demetter, Pieter ;Boterberg, Tom;Delrue, Louke;Peeters, Marc;Van Damme, Nancy
Référence Oncology Reports, 22, 1, page (105-113)
Publication Publié, 2009-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy.
Auteur:	Casneuf, Veerle F; Demetter, Pieter; Boterberg, Tom; Delrue, Louke; Peeters, Marc; Van Damme, Nancy
Informations sur la publication:	Oncology Reports, 22, 1, page (105-113)
Statut de publication:	Publié, 2009-07
Sujet CREF:	Anatomopathologie
	Médecine pathologie humaine
MeSH keywords:	Angiogenesis Inhibitors -- administration & dosage
	Animals
	Antigens, CD95 -- metabolism
	Antimetabolites, Antineoplastic -- administration & dosage
	Antineoplastic Combined Chemotherapy Protocols -- pharmacology
	Apoptosis -- drug effects
	Caspase 3 -- metabolism
	Cell Line, Tumor
	Chemotherapy, Adjuvant
	Deoxycytidine -- administration & dosage -- analogs & derivatives
	Epidermal Growth Factor -- metabolism
	Indoles -- administration & dosage
	Male
	Mice
	Microvessels -- drug effects
	Neovascularization, Pathologic -- drug therapy -- enzymology -- pathology
	Pancreatic Neoplasms -- blood supply -- drug therapy -- enzymology -- pathology -- radiotherapy
	Pregnancy Proteins -- metabolism
	Protein Kinase Inhibitors -- administration & dosage
	Pyrroles -- administration & dosage
	Radiotherapy, Adjuvant
	Time Factors
	Vascular Endothelial Growth Factor A -- metabolism
Note générale:	Comparative Study
	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:1021-335X
	info:pmid/19513511